You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康華生物(300841.SZ):放棄參股公司一曜生物20%股權優先購買權
格隆匯 09-10 08:23

格隆匯9月10日丨康華生物(300841.SZ)公佈,公司於2020年9月9日召開的第一屆董事會第十八次會議審議通過了《關於放棄參股公司股權優先購買權暨與關聯方形成共同投資關係的關聯交易的議案》,公司擬放棄參股公司一曜生物股權轉讓的優先購買權。

公司於2020年7月以自有資金2800萬元收購了一曜生物10.00%股權,成為一曜生物股東。一曜生物註冊資本為3750萬元,主營業務為動物疫苗的研發、生產、銷售和寵物醫療服務。

近日,公司收到一曜生物的股東一曜集團《關於一曜集團擬轉讓其持有廣西一曜20%股權的徵詢意見函》,一曜集團擬將其持有的一曜生物20%股權轉讓給奧聯電子(300585.SZ)。

奧聯電子實際控制人系錢明飛,錢明飛通過平潭盈科盛道創業投資合夥企業(有限合夥)、淄博泰格盈科創業投資中心(有限合夥)間接持有公司5%以上股份,奧聯電子系公司關聯方。

根據《公司法》和一曜生物公司章程的規定,公司對上述轉讓的股權享有同等條件下的優先購買權。公司持有一曜生物10.00%股權,並獲得一曜生物“狂犬病滅活疫苗(PV/BHK-21株)”產品滿足上市銷售條件後的獨家代理銷售權,基於公司自身情況和經營規劃的考慮,公司擬放棄上述股權轉讓的優先購買權。

鑑於該次交易受讓方奧聯電子為公司關聯方,公司放棄上述股權的優先購買權構成關聯交易,該次交易完成後一曜生物成為公司與關聯方奧聯電子共同投資的企業,公司與關聯方奧聯電子形成共同投資關係。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account